Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04312958 · ClinicalTrials.gov registry record

Quantra QStat in Trauma and Liver Transplant

A clinical trial of Trauma and Hemorrhage, sponsored by HemoSonics.

Completed
Registry status
397
Enrollment target
10
Study locations

NCT04312958 is a study of Trauma and Hemorrhage that has completed, run by HemoSonics. The registered enrollment target is 397 participants, above the 300-participant average among 56 other Trauma trials with a reported enrollment target (32% higher). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04312958, a study of Trauma and Hemorrhage, has completed, sponsored by HemoSonics.

COMPLETED
Registry status
397 participants
Enrollment target
10
Study locations

Study Summary

This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.

Interventions

  • DIAGNOSTIC_TEST Quantra System

Study Locations (10)

Texas

  • University of Texas Southwestern Medical Center - Dallas
  • Texas Tech University Health Sciences Center - El Paso

California

  • Zuckerberg San Francisco General Hospital and Trauma Center - San Francisco

Colorado

  • University of Colorado - Denver

Florida

  • University of Florida Health Shands Hospital - Gainesville

Michigan

  • University of Michigan Medical Center - Ann Arbor

Ohio

  • Ohio State University - Columbus

Oklahoma

  • University of Oklahoma Medical Center - Oklahoma City

South Carolina

  • Spartanburg Regional Medical Center - Spartanburg

Trial Details

FieldValue
Enrollment Target 397 participants
Start Date 2020-07-20
Est. Completion 2023-04-13

Sponsor

HemoSonics

24 total trials

What the Registry Record Tells You About NCT04312958

The ClinicalTrials.gov registry entry for NCT04312958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 397 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 300-participant average among 56 other Trauma trials with a reported enrollment target (32% higher). The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Quantra System is the first listed.

NCT04312958 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Texas, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT04312958 about?

NCT04312958 is a clinical study titled "Quantra QStat in Trauma and Liver Transplant". This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.

What is the current status of trial NCT04312958?

This trial is currently completed. The enrollment target is 397 participants. The study started on 2020-07-20. Estimated completion is 2023-04-13.

What conditions does trial NCT04312958 study?

This clinical trial studies the following conditions: Trauma, Hemorrhage, Liver Transplant.

What interventions are being tested in trial NCT04312958?

The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04312958?

This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04312958 being conducted?

This trial has 10 study locations across California, Colorado, Florida, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.